On May 31, 2022, Ultima Genomics emerged from stealth business mode with a new high-throughput, low-cost sequencing platform that delivers the $100 genome. Pre-prints were available on BioRxiv.

Ultimaﾒs goal is to unleash a new era in genomics-driven research and healthcare, and it had secured approximately $600 million in backing from leading investors who share this vision.